Why are you looking at Coherus Oncology?
Capability
Service linesPHARMACEUTICAL PREPARATION MANUFACTURING
Work mix: 100% prime · 0% sub · primary NAICS 325412 / PSC 6505 DRUGS AND BIOLOGICALS
Where they win
Sole agencyRecompete exposure: None
No incumbent recompetes detected in the next 24 months.
Agency buyer map
1 buyersRecompete exposure
NoneNo incumbent recompetes detected in the next 24 months.
No incumbent recompetes detected in the next 24 months.
GET THE FULL BRIEF
Get Coherus Oncology’s recompete exposure, top agencies and teaming history
The outlook above is free to read and verify — an estimated $11.8M in play. Enter a work email for two figures the page cannot show.
“With competitive federal procurements, winning starts with strategically understanding the customer environment to the left of SAM.gov. This is what SCOUT does - a deeper and more precise understanding of what the…”
Enter your company name and we'll build the page.
Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →
Frequently asked questions
What federal contracts does Coherus Oncology hold?
Coherus Oncology (UEI V13JDMAMELK8) shows $11.8M across 3 award actions in SCOUT’s public USASpending-backed profile, with Department of Health and Human Services (HHS) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.
Which agencies does Coherus Oncology work with?
Coherus Oncology’s firm-wide obligated mix is led by Department of Health and Human Services (HHS) (100%).
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →